1. Left Ventricular Assist Device Performance With Long-Term Circulatory Support: Lessons From the REMATCH Trial 
Walter P. Dembitsky, MD, Alfred J. Tector, MD, Soon Park, MD, Alan J. Moskowitz, MD, Annetine C. Gelijns, PhD, Nuala S. Ronan, RN, William Piccione, MD, William L. Holman, MD, Satoshi Furukawa, MD, Alan D. Weinberg, MS, Gerald Heatley, MS, Victor L. Poirier, MBA, Laura Damme, RN, MPH, James W. Long, MD 
The Annals of Thoracic Surgery 
Volume 78, Issue 6, Pages (December 2004)
DOI: /j.athoracsur

2. Fig 1
Freedom from left ventricular assist device (LVAD) failure. This product-limit estimate curve plots the probability of being free of device failure versus time (days) and includes the six device failure events that occurred during the prespecified 24-visit follow-up period. Patients were censored (circles) when they died or when, at the last date of follow-up, they had not experienced a device failure.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

3. Fig 2
Freedom from left ventricular assist device replacement. This product-limit estimate curve plots the probability of being free of device replacement versus time (days). Patients were censored (circles) when they died or when, at the last date of follow-up, they had not undergone a device replacement.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

4. Fig 3
Survival postoperative left ventricular assist device replacement. This product-limit estimate curve plots the probability of survival after device replacement. Circles depict patients who are alive.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )

5. Fig 4
Survival postoperative left ventricular assist device replacement stratified by the presence of sepsis. This product-limit estimate curve plots the probability of survival after device replacement stratified by the cause of device failure (sepsis related replacement versus all other causes). Circles depict patients who are alive.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )